当前位置: 首页 > 详情页

Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150080, Peoples R China; [2]Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [3]Harbin Med Univ, Coll Fundamental Med Sci, Harbin 150080, Peoples R China; [4]Tianjin Med Univ, Gen Hosp, Dept Neurosurg,Minist Educ, Lab Neurooncol,Tianjin Neurol Inst,Lab Neurotraum, Tianjin 300052, Peoples R China; [5]Tianjin Municipal Govt, Tianjin 300052, Peoples R China
出处:
ISSN:

摘要:
Glioma is the most common and fatal primary brain tumour with poor prognosis; however, the functional roles of miRNAs in glioma malignant progression are insufficiently understood. Here, we used an integrated approach to identify miRNA functional targets during glioma malignant progression by combining the paired expression profiles of miRNAs and mRNAs across 160 Chinese glioma patients, and further constructed the functional miRNA-mRNA regulatory network. As a result, most tumour-suppressive miRNAs in glioma progression were newly discovered, whose functions were widely involved in gliomagenesis. Moreover, three miRNA signatures, with different combinations of hub miRNAs (regulations >= 30) were constructed, which could independently predict the survival of patients with all gliomas, high-grade glioma and glioblastoma. Our network-based method increased the ability to identify the prognostic biomarkers, when compared with the traditional method and random conditions. Hsa-miR-524-5p and hsa-miR-628-5p, shared by these three signatures, acted as protective factors and their expression decreased gradually during glioma progression. Functional analysis of these miRNA signatures highlighted their critical roles in cell cycle and cell proliferation in glioblastoma malignant progression, especially hsa-miR-524-5p and hsa-miR-628-5p exhibited dominant regulatory activities. Therefore, network-based biomarkers are expected to be more effective and provide deep insights into the molecular mechanism of glioma malignant progression.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 2 区 生物
小类 | 2 区 生化与分子生物学
最新[2025]版:
大类 | 2 区 生物学
小类 | 2 区 生化与分子生物学
JCR分区:
出版当年[2011]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150080, Peoples R China;
通讯作者:
通讯机构: [1]Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150080, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17044 今日访问量:2 总访问量:913 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院